Sign in Subscribe
Machine learning

Breakthrough Blood Test Detects Ovarian Cancer with Unprecedented Accuracy

Strategic Insights

— 1 min read

A new blood test developed by AOA Dx has shown unprecedented accuracy in detecting ovarian cancer in its early stages, with a potential to significantly improve patient care and outcomes. The test uses machine learning to recognize patterns in lipids and proteins shed into the bloodstream by cancer cells, offering a promising diagnostic tool for the disease. With around 7,500 new cases of ovarian cancer diagnosed in the UK every year, a more accurate and early detection method is crucial in improving patient outcomes and reducing healthcare costs.

Key Takeaways:

  • The AOA Dx blood test uses machine learning to detect ovarian cancer by analyzing lipids and proteins shed into the bloodstream by cancer cells.
  • The test was tested on 832 samples and showed high accuracy rates, with 93% detection rate at all stages and 91% in early stages in samples from the University of Colorado.
  • In Manchester samples, the test showed 92% accuracy at all stages and 88% accuracy in early stages.
  • The test has the potential to improve patient care and outcomes for women diagnosed with ovarian cancer.
  • Experts are hopeful that the test could one day be used on the NHS, subject to regulatory approval.
  • Ovarian cancer is typically diagnosed using a mix of scans and blood tests, but is often detected too late when it is harder to treat.
  • Symptoms of ovarian cancer may not always be obvious, and include persistent pain in the abdomen or pelvis, feeling full quickly after eating, and peeing frequently.

Statistics:

  • 7,500 new cases of ovarian cancer are diagnosed in the UK every year.
  • The test was tested on 832 samples.
  • 93% detection rate at all stages in samples from the University of Colorado.
  • 91% detection rate in early stages in samples from the University of Colorado.
  • 92% accuracy at all stages in samples from Manchester.
  • 88% accuracy in early stages in samples from Manchester.

Sources:

  • AOA Dx press release.
  • University of Manchester press release.
  • American Association of Cancer Research (AACR) journal Cancer Research Communications, study published by researchers at the universities of Manchester and Colorado.

Read more